A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.
about
A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
A randomized phase 2 study of ...... gnosed acute myeloid leukemia.
@en
A randomized phase 2 study of ...... gnosed acute myeloid leukemia.
@nl
type
label
A randomized phase 2 study of ...... gnosed acute myeloid leukemia.
@en
A randomized phase 2 study of ...... gnosed acute myeloid leukemia.
@nl
prefLabel
A randomized phase 2 study of ...... gnosed acute myeloid leukemia.
@en
A randomized phase 2 study of ...... gnosed acute myeloid leukemia.
@nl
P2093
P2860
P50
P356
P1433
P1476
A randomized phase 2 study of ...... gnosed acute myeloid leukemia.
@en
P2093
Courtney D DiNardo
Koji Sasaki
Lianchun Xiao
Mark Brandt
Naval G Daver
Naveen Pemmaraju
Nitin Jain
Susan M O'Brien
Tapan M Kadia
Varsha Gandhi
P2860
P304
P356
10.1002/CNCR.30883
P407
P50
P577
2017-07-14T00:00:00Z